biomedicina slovenica

id=183060 : 1

1. Ciuleanu Tudor; Ocvirk Janja
   A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer
   2007 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics